nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—multiple sclerosis—amyotrophic lateral sclerosis	0.912	1	CtDrD
Methylprednisolone—Personality change—Riluzole—amyotrophic lateral sclerosis	0.00675	0.0784	CcSEcCtD
Methylprednisolone—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.00347	0.0404	CcSEcCtD
Methylprednisolone—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0268	CcSEcCtD
Methylprednisolone—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0234	CcSEcCtD
Methylprednisolone—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0216	CcSEcCtD
Methylprednisolone—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0212	CcSEcCtD
Methylprednisolone—Mania—Riluzole—amyotrophic lateral sclerosis	0.00178	0.0207	CcSEcCtD
Methylprednisolone—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0201	CcSEcCtD
Methylprednisolone—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00172	0.02	CcSEcCtD
Methylprednisolone—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00164	0.019	CcSEcCtD
Methylprednisolone—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0186	CcSEcCtD
Methylprednisolone—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0183	CcSEcCtD
Methylprednisolone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0171	CcSEcCtD
Methylprednisolone—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0165	CcSEcCtD
Methylprednisolone—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00138	0.016	CcSEcCtD
Methylprednisolone—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00129	0.015	CcSEcCtD
Methylprednisolone—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0143	CcSEcCtD
Methylprednisolone—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0136	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0134	CcSEcCtD
Methylprednisolone—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0129	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0126	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0126	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00104	0.012	CcSEcCtD
Methylprednisolone—Injury—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0119	CcSEcCtD
Methylprednisolone—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.001	0.0116	CcSEcCtD
Methylprednisolone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.001	0.0116	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.000971	0.0113	CcSEcCtD
Methylprednisolone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.000963	0.0112	CcSEcCtD
Methylprednisolone—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00094	0.0109	CcSEcCtD
Methylprednisolone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000925	0.0107	CcSEcCtD
Methylprednisolone—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000918	0.0107	CcSEcCtD
Methylprednisolone—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000893	0.0104	CcSEcCtD
Methylprednisolone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00089	0.0103	CcSEcCtD
Methylprednisolone—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.000849	0.00987	CcSEcCtD
Methylprednisolone—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00963	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00963	CcSEcCtD
Methylprednisolone—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000817	0.0095	CcSEcCtD
Methylprednisolone—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000796	0.00925	CcSEcCtD
Methylprednisolone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000739	0.00859	CcSEcCtD
Methylprednisolone—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000724	0.00841	CcSEcCtD
Methylprednisolone—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000724	0.00841	CcSEcCtD
Methylprednisolone—Fluocinolone Acetonide—PLA2G4A—amyotrophic lateral sclerosis	0.000721	0.488	CrCbGaD
Methylprednisolone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000714	0.00829	CcSEcCtD
Methylprednisolone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00071	0.00825	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00071	0.00825	CcSEcCtD
Methylprednisolone—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000694	0.00807	CcSEcCtD
Methylprednisolone—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000662	0.00769	CcSEcCtD
Methylprednisolone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000653	0.00759	CcSEcCtD
Methylprednisolone—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000652	0.00757	CcSEcCtD
Methylprednisolone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00755	CcSEcCtD
Methylprednisolone—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000647	0.00751	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000639	0.00742	CcSEcCtD
Methylprednisolone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00706	CcSEcCtD
Methylprednisolone—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000603	0.00701	CcSEcCtD
Methylprednisolone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00059	0.00685	CcSEcCtD
Methylprednisolone—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000587	0.00682	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000586	0.00681	CcSEcCtD
Methylprednisolone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000581	0.00675	CcSEcCtD
Methylprednisolone—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000569	0.00662	CcSEcCtD
Methylprednisolone—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000566	0.00657	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000525	0.0061	CcSEcCtD
Methylprednisolone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000517	0.00601	CcSEcCtD
Methylprednisolone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00051	0.00593	CcSEcCtD
Methylprednisolone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000508	0.00591	CcSEcCtD
Methylprednisolone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000507	0.0059	CcSEcCtD
Methylprednisolone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000497	0.00578	CcSEcCtD
Methylprednisolone—Fluticasone Propionate—PLA2G4A—amyotrophic lateral sclerosis	0.000493	0.334	CrCbGaD
Methylprednisolone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00049	0.0057	CcSEcCtD
Methylprednisolone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000488	0.00568	CcSEcCtD
Methylprednisolone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000482	0.0056	CcSEcCtD
Methylprednisolone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000482	0.0056	CcSEcCtD
Methylprednisolone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00048	0.00558	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000478	0.00556	CcSEcCtD
Methylprednisolone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000476	0.00553	CcSEcCtD
Methylprednisolone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000466	0.00541	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000462	0.00537	CcSEcCtD
Methylprednisolone—Infection—Riluzole—amyotrophic lateral sclerosis	0.000459	0.00533	CcSEcCtD
Methylprednisolone—Shock—Riluzole—amyotrophic lateral sclerosis	0.000454	0.00528	CcSEcCtD
Methylprednisolone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000453	0.00526	CcSEcCtD
Methylprednisolone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00524	CcSEcCtD
Methylprednisolone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000449	0.00521	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000446	0.00519	CcSEcCtD
Methylprednisolone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000431	0.00501	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000421	0.00489	CcSEcCtD
Methylprednisolone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000418	0.00485	CcSEcCtD
Methylprednisolone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000415	0.00482	CcSEcCtD
Methylprednisolone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000406	0.00472	CcSEcCtD
Methylprednisolone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000398	0.00463	CcSEcCtD
Methylprednisolone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000381	0.00442	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000378	0.00439	CcSEcCtD
Methylprednisolone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000367	0.00426	CcSEcCtD
Methylprednisolone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000365	0.00424	CcSEcCtD
Methylprednisolone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00034	0.00395	CcSEcCtD
Methylprednisolone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000331	0.00385	CcSEcCtD
Methylprednisolone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000327	0.0038	CcSEcCtD
Methylprednisolone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000316	0.00367	CcSEcCtD
Methylprednisolone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000305	0.00355	CcSEcCtD
Methylprednisolone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000294	0.00341	CcSEcCtD
Methylprednisolone—Rash—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00338	CcSEcCtD
Methylprednisolone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00338	CcSEcCtD
Methylprednisolone—Headache—Riluzole—amyotrophic lateral sclerosis	0.000289	0.00336	CcSEcCtD
Methylprednisolone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000274	0.00319	CcSEcCtD
Methylprednisolone—Triamcinolone—PTGS2—amyotrophic lateral sclerosis	0.000115	0.0778	CrCbGaD
Methylprednisolone—Betamethasone—PTGS2—amyotrophic lateral sclerosis	9.42e-05	0.0637	CrCbGaD
Methylprednisolone—Dexamethasone—PTGS2—amyotrophic lateral sclerosis	5.48e-05	0.0371	CrCbGaD
